Observational studyHaematologica2022

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.

Amira Marouf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.